rxstat › Shortages › Abiraterone
Abiraterone shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Abiraterone products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
In shortage since
Jun 8, 2026
Est. full return
Sep 4, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageSANDOZ ABIRATERONE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02521644 · since Jun 8, 2026, est. end Sep 4, 2026 · Delay in shipping of the drug.
ResolvedSANDOZ ABIRATERONE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02521644 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ ABIRATERONE
250MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02486393 · ended May 12, 2025 · Requirements related to complying with good manufacturing practices.
ResolvedMAR-ABIRATERONE
250MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02503980 · ended May 1, 2025 · Delay in shipping of the drug.
ResolvedSANDOZ ABIRATERONE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02521644 · ended Feb 17, 2025 · Demand increase for the drug.
ResolvedAPO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Feb 29, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-ABIRATERONE FILM COATED TABLETS
500MG · TABLET · APOTEX INC
DIN 02491400 · ended Nov 16, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Nov 16, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-ABIRATERONE FILM COATED TABLETS
500MG · TABLET · APOTEX INC
DIN 02491400 · ended Aug 1, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Jul 12, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-ABIRATERONE FILM COATED TABLETS
500MG · TABLET · APOTEX INC
DIN 02491400 · ended Jul 12, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Jan 9, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
Abiraterone is currently affected by an active shortage report filed with Health Canada by SANDOZ CANADA INCORPORATED.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Abiraterone is classified under “HORMONE ANTAGONISTS AND RELATED AGENTS” (ATC L02BX).
Recent changes
Common questions
When will Abiraterone be back in stock in Canada?
The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Abiraterone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All hormone antagonists and related agents shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.